Correction: pFAK-Y397 Overexpression as Both a Prognostic and a Predictive Biomarker for Patients With Metastatic Osteosarcoma

PLoS ONE - United States
doi 10.1371/journal.pone.0188991
Full Text
Abstract

Available in full text

Date
Authors

Unknown

Publisher

Public Library of Science (PLoS)

Related search

sCLU as Prognostic Biomarker and Therapeutic Target in Osteosarcoma

Bioengineered
Applied MicrobiologyBiotechnologyMedicineBioengineering
2019English

KDR Gene as a Predictive Biomarker of Response to Regorafenib in Patients With Metastatic Colorectal Cancer (mCRC)

Journal of Pharmacogenomics & Pharmacoproteomics
2017English

Finding a New Prognostic Biomarker for Metastatic Colorectal Cancer

Journal of the Korean Society of Coloproctology
2012English

LncRNA SOX2-OT Is a Novel Prognostic Biomarker for Osteosarcoma Patients and Regulates Osteosarcoma Cells Proliferation and Motility Through Modulating SOX2

IUBMB Life
BiochemistryGeneticsClinical BiochemistryCell BiologyMolecular Biology
2017English

Conversion Surgery in Metastatic Gastric Cancer and Cancer Dormancy as a Prognostic Biomarker

Cancers
Cancer ResearchOncology
2019English

RIPK3 Expression as a Potential Predictive and Prognostic Marker in Metastatic Colon Cancer

Clinical and Investigative Medicine
Medicine
2019English

Identification of F5 as a Prognostic Biomarker in Patients With Gastric Cancer

BioMed Research International
ImmunologyMolecular BiologyBiochemistryMicrobiology MedicineGenetics
2020English

Anti-Mda5 Antibody as a Potential Diagnostic and Prognostic Biomarker in Patients With Dermatomyositis

Oncotarget
Oncology
2017English

Circular RNA Hsa_circ_0078602 May Have Potential as a Prognostic Biomarker for Patients With Hepatocellular Carcinoma

Oncology Letters
Cancer ResearchOncology
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy